神經調節器市場：按產品、用途和最終用戶分類 - 全球預測 2023-2030

預計2023年全球神經調節劑市場將大幅成長，達86.6136億美元，複合年成長率為13.47%，2030年將達210.726億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球神經調節劑市場至關重要。透過檢驗業務策略和產品滿意度等關鍵指標，它可以對供應商進行全面評估，使用戶能夠根據自己的特定需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 神經調節劑的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球神經調節劑市場的阻礙因素和影響為何？

3.在預測期內，全球神經調節劑市場需要投資哪些產品/細分市場/應用/領域？

4.全球神經調節劑市場的競爭策略為何？

5. 全球神經調節劑市場的技術趨勢和法律規範是什麼？

6.全球神經調節劑市場主要廠商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入全球神經調節劑市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 神經系統疾病和損傷的盛行率上升
    • 對神經調節和神經刺激技術的日益關注
    • 擴大神經調節的應用
  • 抑制因素
    • 神經調節程序的高成本
  • 機會
    • 政府對神經系統疾病研究的支持
    • 新型神經調節劑的開發
  • 任務
    • 嚴格的法規結構和漫長的核准流程
    • 世界各地缺乏技術專長
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 神經調節劑市場：副產品

• 深層腦部刺激器
• 薦神經刺激設備
• 脊髓刺激設備
• 經顱磁刺激器
• 迷走神經刺激設備

第7章 神經調節劑市場：依用途

• 神經系統疾病
• 疼痛管理
• 呼吸系統疾病

第8章 神經調節器市場：依最終用戶分類

• 醫院
• 專科診所及門診中心

第9章 美洲神經調節劑市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太神經調節劑市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲/中東/非洲神經調節劑市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Neuromodulation Devices Market is forecasted to grow significantly, with a projected USD 8,661.36 million in 2023 at a CAGR of 13.47% and expected to reach a staggering USD 21,072.60 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Neuromodulation Devices Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Neuromodulation Devices Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Transcranial Magnetic Stimulators, and Vagus Nerve Stimulators. The Vagus Nerve Stimulators is projected to witness significant market share during forecast period.

Based on Application, market is studied across Neurological Disorders, Pain Management, and Respiratory Disorders. The Respiratory Disorders is projected to witness significant market share during forecast period.

Based on End User, market is studied across Hospitals and Specialty Clinics & Ambulatory Centers. The Specialty Clinics & Ambulatory Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Neuromodulation Devices Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neuromodulation Devices Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuromodulation Devices Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuromodulation Devices Market?

4. What is the competitive strategic window for opportunities in the Global Neuromodulation Devices Market?

5. What are the technology trends and regulatory frameworks in the Global Neuromodulation Devices Market?

6. What is the market share of the leading vendors in the Global Neuromodulation Devices Market?

7. What modes and strategic moves are considered suitable for entering the Global Neuromodulation Devices Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Neuromodulation Devices Market, by Product, 2022 vs 2030
• 4.3. Neuromodulation Devices Market, by Application, 2022 vs 2030
• 4.4. Neuromodulation Devices Market, by End User, 2022 vs 2030
• 4.5. Neuromodulation Devices Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of neurological disorders and nerve injuries
    • 5.1.1.2. Growing focus on neuromodulation & neurostimulation technologies
    • 5.1.1.3. Expanding applications of neuromodulation
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of neuromodulation procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Government support for research on neurological disorders
    • 5.1.3.2. Development of novel neuromodulation devices
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory frameworks and time-consuming approval processes
    • 5.1.4.2. Lack of technical expertise across the globe
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Neuromodulation Devices Market, by Product

• 6.1. Introduction
• 6.2. Deep Brain Stimulators
• 6.3. Sacral Nerve Stimulators
• 6.4. Spinal Cord Stimulators
• 6.5. Transcranial Magnetic Stimulators
• 6.6. Vagus Nerve Stimulators

7. Neuromodulation Devices Market, by Application

• 7.1. Introduction
• 7.2. Neurological Disorders
• 7.3. Pain Management
• 7.4. Respiratory Disorders

8. Neuromodulation Devices Market, by End User

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Specialty Clinics & Ambulatory Centers

9. Americas Neuromodulation Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Neuromodulation Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Neuromodulation Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. NEUROMODULATION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. NEUROMODULATION DEVICES MARKET SIZE, 2022 VS 2030
• FIGURE 3. NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 7. NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. NEUROMODULATION DEVICES MARKET DYNAMICS
• FIGURE 9. NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. NEUROMODULATION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. NEUROMODULATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. NEUROMODULATION DEVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 15. NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. NEUROMODULATION DEVICES MARKET SIZE, BY SPECIALTY CLINICS & AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CHINA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ITALY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. POLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. QATAR NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 145. NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 146. NEUROMODULATION DEVICES MARKET LICENSE & PRICING